Analyst Ratings for Edwards Lifesciences (EW) [Neutrals]
EW Rating Summary
EW Price Target Summary
- Highest: $117.00 (Janney Montgomery Scott)
- Lowest: $64.00 (UBS)
- Average: $92.13
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
$92.13 (+37.4%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/24/2013 | RBC Capital | Downgrade | Sector Perform (Outperform) |
72.00 (100.00) |
82.81 | 67.06 | -19.02% | Details |
| 4/24/2013 | Lazard Capital | Downgrade | Neutral (Buy) |
N/A (N/A) |
82.81 | 67.06 | -19.02% | Details |
| 1/4/2013 | JMP Securities | New Coverage | Market Perform (N/A) |
N/A (N/A) |
92.52 | 67.06 | -27.52% | Details |
| 10/22/2012 | Citi | Downgrade | Neutral (Buy) |
N/A (N/A) |
86.14 | 67.06 | -22.15% | Details |
| 7/13/2012 | Credit Suisse | Downgrade | Neutral (Outperform) |
N/A (N/A) |
100.82 | 67.06 | -33.49% | Details |
| 1/3/2012 | JPMorgan | Upgrade | Neutral (N/A) |
79.00 (N/A) |
70.70 | 67.06 | -5.15% | Details |
| 9/23/2011 | Barclays » Updated 10/9/2012 |
Downgrade | Equalweight (N/A) |
85.00 (90.00) |
74.67 | 67.06 | -10.19% | Details |
| 8/24/2011 | Wunderlich Securities | New Coverage | Hold (N/A) |
75.00 (N/A) |
70.69 | 67.06 | -5.14% | Details |
| 8/15/2011 | Rodman & Renshaw | Upgrade | Market Perform (N/A) |
N/A (N/A) |
69.15 | 67.06 | -3.02% | Details |
| 6/15/2011 | Brean Capital | New Coverage | Hold (N/A) |
N/A (N/A) |
85.58 | 67.06 | -21.64% | Details |
| 4/21/2011 | Wedbush | Upgrade | Neutral (N/A) |
N/A (N/A) |
84.36 | 67.06 | -20.51% | Details |
| 9/24/2010 | Noble Financial | Downgrade | Hold (N/A) |
N/A (N/A) |
66.54 | 67.06 | 0.78% | Details |
| 9/10/2010 | Deutsche Bank » Updated 9/29/2011 |
New Coverage | Hold (N/A) |
75.00 (N/A) |
59.76 | 67.06 | 12.22% | Details |
| 7/7/2010 | BMO Capital | Downgrade | Market Perform (N/A) |
N/A (N/A) |
56.60 | 67.06 | 18.48% | Details |
